Venkatraman Ramakrishnan

Venkatraman Ramakrishnan
Name	Venkatraman Ramakrishnan
Birth date	1952
Birth place	Chidambaram, Tamil Nadu
Nationality	Indian / British / United States
Field	Structural biology, biochemistry, molecular biology
Work institutions	Rutgers University, University of Cambridge, Medical Research Council Laboratory of Molecular Biology, Royal Society
Alma mater	University of Madras, Jawaharlal Nehru University, Ohio University, Rutgers University, University of California, Berkeley
Known for	Ribosome structure, cryo‑EM, X‑ray crystallography
Prizes	Nobel Prize in Chemistry, Fellow of the Royal Society, Royal Medal

Contents

Venkatraman Ramakrishnan is an Indian-born structural biologist noted for determining the structure and function of the ribosome, work that earned him the Nobel Prize in Chemistry alongside Thomas A. Steitz and Ada Yonath. He has held positions at Rutgers University, the Medical Research Council Laboratory of Molecular Biology, and the University of Cambridge, and has been a Fellow of the Royal Society and a member of scientific organizations including the National Academy of Sciences and the European Molecular Biology Organization.

Early life and education

Born in Chidambaram, Tamil Nadu, Ramakrishnan attended the University of Madras for undergraduate studies before moving to Jawaharlal Nehru University and later to Ohio University and Rutgers University for graduate training in biochemistry and molecular biology. He completed a PhD under advisors connected with research at Rutgers University and pursued postdoctoral work at University of California, Berkeley and at institutions associated with X-ray crystallography and electron microscopy techniques such as laboratories influenced by work at the Laboratory of Molecular Biology in Cambridge. His early mentors and collaborators included scientists from Harvard University, Massachusetts Institute of Technology, Cold Spring Harbor Laboratory, and Max Planck Institute groups studying ribosome components and transfer RNA.

Ramakrishnan's career spans appointments at Rutgers University, a move to the United Kingdom to join the Medical Research Council Laboratory of Molecular Biology in Cambridge, and a Professorship at the University of Cambridge and a Fellowship at Trinity College, Cambridge. His laboratory applied X-ray crystallography and later cryo-electron microscopy methods to determine high-resolution structures of the 30S ribosomal subunit, contributing to understanding of translation mechanisms, antibiotic binding such as to tetracycline and aminoglycoside classes, and interactions with mRNA and tRNA. Collaborations and technical exchanges with groups at Columbia University, Yale University, Princeton University, University of Oxford, EMBL, Weizmann Institute of Science, Max Planck Institute for Biophysical Chemistry, Stanford University, and Scripps Research helped refine models of decoding and fidelity. His work advanced structural studies relevant to antimicrobial resistance by mapping binding sites for drugs studied by researchers at Centers for Disease Control and Prevention and companies such as Pfizer, GlaxoSmithKline, and Novartis. He served on advisory boards for institutions including the Wellcome Trust, the National Institutes of Health, the European Research Council, the Human Frontier Science Program, and industrial partnerships with Thermo Fisher Scientific and Schrödinger.

Ramakrishnan shared the Nobel Prize in Chemistry (2009) with Thomas A. Steitz and Ada Yonath for studies of the structure and function of the ribosome, joining laureates from institutions such as Yale University, Massachusetts Institute of Technology, and Weizmann Institute of Science. He has received honors including election to the Royal Society, the Royal Medal, membership in the United States National Academy of Sciences, a Fellow of Trinity College, Cambridge appointment, the EMBO membership, and international awards presented by organizations like the Royal Society of Chemistry, the American Society for Microbiology, the Indian National Science Academy, and the European Molecular Biology Organization. He has delivered named lectures at venues such as Harvard University, MIT, Oxford University, Cambridge University, Karolinska Institutet, ETH Zurich, Max Planck Society, and the Gordon Research Conferences and been awarded honorary degrees from universities including University of Oxford, University of Cambridge, University of Edinburgh, Princeton University, Yale University, and University of Tokyo.

Ramakrishnan has been involved with scientific societies including the Royal Society, the National Academy of Sciences, and the Indian National Science Academy, and has engaged in science policy discussions with bodies such as the Wellcome Trust and the European Commission. He has connections to academic communities in India, the United Kingdom, and the United States, interacting with colleagues from IIT Madras, Indian Institute of Science, University of Delhi, Trinity College, Cambridge, MRC, and Cold Spring Harbor Laboratory. Public-facing activities have included interviews and profiles in outlets like Nature (journal), Science (journal), The Lancet, and appearances at events organized by Royal Institution and World Economic Forum panels.

Key publications include high-impact articles in Nature (journal), Science (journal), and Cell (journal) describing the structure of the 30S ribosomal subunit, mechanistic studies of decoding, and antibiotic interactions, coauthored with scientists from EMBL, Weizmann Institute of Science, University of Cambridge, Rutgers University, and Harvard Medical School. His work built on foundational studies by William Lawrence Bragg, Max Perutz, John Desmond Bernal, Ada Yonath, and Thomas A. Steitz and influenced later research by groups at Stanford University School of Medicine, Columbia University Irving Medical Center, Weill Cornell Medicine, Scripps Research Institute, and Johns Hopkins University. Selected monographs and reviews appeared in collections edited by Cold Spring Harbor Laboratory Press, Oxford University Press, and Springer Nature. His structural models are deposited in archives maintained by Protein Data Bank and have been cited across literature in antibiotic resistance research, ribosome biogenesis studies, and therapeutic design efforts at companies like Roche and GlaxoSmithKline.